other · Food and Drug Administration · Rule · Published 2006-03-23 · Effective 2006-03-23 · 71 FR 14642
Document
Document number
06-2791
Federal Register citation
71 FR 14642
CFR reference
21 CFR 520
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2006-03-23
Effective date
2006-03-23
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The supplemental NADA provides for revised animal safety labeling for orbifloxacin tablets used in dogs and cats for the management of diseases associated with susceptible bacteria.